IL17A and atherosclerosis: The KEGG enrichment analysis in our study indicated that the main signaling pathways involved in the treatment of ONFH by YGY are lipid and atherosclerosis signaling pathway, IL-17 signaling pathway, HIF-1 signaling pathway, relaxin signaling pathway, MAPK signaling pathway, and so on.